Susan Ellenberg and Holly Fernandez-Lynch of the Perelman School of Medicine commented on U.S. Rep. Andy Harris’s role in overseeing the trials of a coronavirus drug. “The concern about bias wouldn’t arise unless the decision-making [on data from the trial] was difficult,” said Ellenberg. “If the data are such that it's a hard call as to whether to stop the study or not, that's when the personal connections seep into consciousness.”

September 17, 2020 ・ From Politico.com